Tumor necrosis factor-neuropeptide y cross talk regulates inflammation, epithelial barrier functions, and colonic motility

Inflammatory Bowel Diseases

Volumn 19, Issue 12, 2013, Pages 2535-2546

  Chandrasekharan, Bindu ^a   Jeppsson, Sabrina ^a   Pienkowski, Stefan ^a   Belsham, Denise D ^b   Sitaraman, Shanthi V ^a   Merlin, Didier ^c,d   Kokkotou, Efi ^e   Nusrat, Asma ^a   Tansey, Malu G ^f   Srinivasan, Shanthi ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c GEORGIA STATE UNIVERSITY   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f EMORY UNIVERSITY   (United States)

Author keywords

Barrier functions; Colonic motility; Enteric neurons; Experimental colitis; NPY; TNF

Indexed keywords

CLAUDIN 2; ETANERCEPT; INDUCIBLE NITRIC OXIDE SYNTHASE; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL; PROTEIN C JUN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; XPRO 1595;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; CELL SURVIVAL; COLITIS; COLON MOTILITY; CONTROLLED STUDY; CYTOKINE RESPONSE; EXPLANT; GENE SILENCING; IN VITRO STUDY; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL MEMBRANE PERMEABILITY; CHROMATIN IMMUNOPRECIPITATION; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; ELECTRIC CONDUCTIVITY; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL MUCOSA; LASER CAPTURE MICRODISSECTION; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888354417     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000437042.59208.9f     Document Type: Article

References (49)

1. Gallowitsch-Puerta M, Pavlov VA. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci. 2007;80:2325-2329.
2. Gad M, Pedersen AE, Kristensen NN, et al. Blockage of the neurokinin 1 receptor and capsaicin-induced ablation of the enteric afferent nerves protect SCID mice against T-cell-induced chronic colitis. Inflamm Bowel Dis. 2009;15:1174-1182.
3. Margolis KG, Stevanovic K, Karamooz N, et al. Enteric neuronal density contributes to the severity of intestinal inflammation. Gastroenterology. 2011;141:588-598, 598 e1-2.
4. Sang Q, Young HM. Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse. Cell Tissue Res. 1996;284:39-53.
5. Wheway J, Herzog H, Mackay F. The Y1 receptor for NPY: a key modulator of the adaptive immune system. Peptides. 2007;28:453-458.
6. Klompus M, Ho W, Sharkey KA, et al. Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSSinduced colitis. Regul Pept. 2010;165:138-145.
7. Wheway J, Mackay CR, Newton RA, et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med. 2005; 202:1527-1538.
8. Chandrasekharan B, Bala V, Kolachala VL, et al. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS One. 2008;3: e3304.
9. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362: 1383-1395.
10. Matsuda R, Koide T, Tokoro C, et al. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent disease. Inflamm Bowel Dis. 2009;15:328-334.
11. Mankertz J, Amasheh M, Krug SM, et al. TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res. 2009;336:67-77.
12. Czeschik JC, Hagenacker T, Schafers M, et al. TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett. 2008;434: 293-298.
13. Hermann GE, Rogers RC. TNFalpha: a trigger of autonomic dysfunction. Neuroscientist. 2008;14:53-67.
14. Rehn M, Hubschle T, Diener M. TNF-alpha hyperpolarizes membrane potential and potentiates the response to nicotinic receptor stimulation in cultured rat myenteric neurones. Acta Physiol Scand. 2004;181:13-22.
15. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541-546.
16. Anitha M, Chandrasekharan B, Salgado JR, et al. Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y. Gastroenterology. 2006;131:1164-1178.
17. Chandrasekharan BP, Kolachala VL, Dalmasso G, et al. Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility. FASEB J. 2009;23:2727-2734.
18. Mayer CM, Cai F, Cui H, et al. Analysis of a repressor region in the human neuropeptide Y gene that binds Oct-1 and Pbx-1 in GT1-7 neurons. Biochem Biophys Res Commun. 2003;307:847-854.
19. Titolo D, Cai F, Belsham DD. Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) alpha to ERbeta in clonal hypothalamic neurons. Mol Endocrinol. 2006;20:2080-2092.
20. Laukoetter MG, Nava P, Lee WY, et al. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med. 2007;204:3067-3076.
21. Anitha M, Joseph I, Ding X, et al. Characterization of fetal and postnatal enteric neuronal cell lines with improvement in intestinal neural function. Gastroenterology. 2008;134:1424-1435.
22. Hollander D. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg? Am J Gastroenterol. 2002;97:1867-1868.
23. Fischer A, Gluth M, Pape UF, et al. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-alpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2013;304:G970-G979.
24. Saksena S, Tyagi S, Goyal S, et al. Stimulation of apical Cl/HCO(OH) exchanger, SLC26A3 by neuropeptide Y is lipid raft dependent. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1334-G1343.
25. Prasad S, Mingrino R, Kaukinen K, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest. 2005;85:1139-1162.
26. Franze E, Caruso R, Stolfi C, et al. High expression of the "A Disintegrin and Metalloprotease" 19 (ADAM19), a sheddase for TNF-alpha in the mucosa of patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2013;19:501-511.
27. Knutson CG, Mangerich A, Zeng Y, et al. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A. 2013;110:E2332-E2341.
28. Krzystek-Korpacka M, Neubauer K, Berdowska I, et al. Enhanced formation of advanced oxidation protein products in IBD. Inflamm Bowel Dis. 2008;14:794-802.
29. Lundberg S, Holst M, Hellstrom PM. Expression of iNOS mRNA associated with suppression of colonic contraction in rat colitis. Acta Physiol (Oxf). 2006;187:489-494.
30. Chandrasekharan B, Anitha M, Blatt R, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011;23:131-138, e26.
31. Gulbransen BD, Bashashati M, Hirota SA, et al. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med. 2012;18:600-604.
32. Camilleri M, Carlson P, McKinzie S, et al. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil. 2011;23:935-e398.
33. Al-Jarallah A, Oriowo MA, Khan I. Mechanism of reduced colonic contractility in experimental colitis: role of sarcoplasmic reticulum pump isoform-2. Mol Cell Biochem. 2007;298:169-178.
34. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med. 1996; 334:1106-1115.
35. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344-1367.
36. Herdegen T, Leah JD. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev. 1998;28: 370-490.
37. Son SJ, Lee KM, Jeon SM, et al. Activation of transcription factor c-jun in dorsal root ganglia induces VIP and NPY upregulation and contributes to the pathogenesis of neuropathic pain. Exp Neurol. 2007;204:467-472.
38. Gassler N, Rohr C, Schneider A, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol. 2001;281:G216-G228.
39. Weber CR, Raleigh DR, Su L, et al. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem. 2010;285:12037-12046.
40. Cox HM, Cuthbert AW. Neuropeptide Y antagonises secretagogue evoked chloride transport in rat jejunal epithelium. Pflugers Arch. 1988; 413:38-42.
41. Cox HM, Cuthbert AW, Hakanson R, et al. The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol. 1988;398:65-80.
42. Talley AK, Dewhurst S, Perry SW, et al. Tumor necrosis factor alphainduced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol. 1995;15: 2359-2366.
43. Zalevsky J, Secher T, Ezhevsky SA, et al. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol. 2007;179:1872-1883.
44. McAlpine FE, Lee JK, Harms AS, et al. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents preplaque amyloid-associated neuropathology. Neurobiol Dis. 2009;34: 163-177.
45. Martinez TN, Chen X, Bandyopadhyay S, et al. Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons. Mol Neurodegener. 2012;7:45.
46. Marchetti L, Klein M, Schlett K, et al. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem. 2004;279:32869-32881.
47. Gougeon PY, Lourenssen S, Han TY, et al. The pro-inflammatory cytokines IL-1beta and TNFalpha are neurotrophic for enteric neurons. J Neurosci. 2013;33:3339-3351.
48. Agasse F, Bernardino L, Kristiansen H, et al. Neuropeptide Y promotes neurogenesis in murine subventricular zone. Stem Cells. 2008;26: 1636-1645.
49. Alvaro AR, Martins J, Araujo IM, et al. Neuropeptide Y stimulates retinal neural cell proliferation - involvement of nitric oxide. J Neurochem. 2008;105:2501-2510.